These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 18319498

  • 1. Teriparatide in the treatment of osteoporosis.
    Stroup J, Kane MP, Abu-Baker AM.
    Am J Health Syst Pharm; 2008 Mar 15; 65(6):532-9. PubMed ID: 18319498
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD, Hanley DA, Lorraine JK, Yu M.
    Clin Ther; 2007 Sep 15; 29(9):2055-67. PubMed ID: 18035204
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Management of postmenopausal osteoporosis and the prevention of fractures.
    Gambacciani M, Levancini M.
    Panminerva Med; 2014 Jun 15; 56(2):115-31. PubMed ID: 24942322
    [Abstract] [Full Text] [Related]

  • 8. Treatment of osteoporosis with parathyroid hormone and teriparatide.
    Pleiner-Duxneuner J, Zwettler E, Paschalis E, Roschger P, Nell-Duxneuner V, Klaushofer K.
    Calcif Tissue Int; 2009 Mar 15; 84(3):159-70. PubMed ID: 19189037
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anabolic therapies for osteoporosis.
    Uihlein AV, Leder BZ.
    Endocrinol Metab Clin North Am; 2012 Sep 15; 41(3):507-25. PubMed ID: 22877427
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Teriparatide: an anabolic drug for the treatment of patients with osteoporosis].
    Lems WF, Hamdy NA, Netelenbos JC.
    Ned Tijdschr Geneeskd; 2006 Jan 21; 150(3):132-7. PubMed ID: 16463613
    [Abstract] [Full Text] [Related]

  • 17. Combined Pharmacologic Therapy in Postmenopausal Osteoporosis.
    Shen Y, Gray DL, Martinez DS.
    Endocrinol Metab Clin North Am; 2017 Mar 21; 46(1):193-206. PubMed ID: 28131133
    [Abstract] [Full Text] [Related]

  • 18. [Teriparatide: human recombinant parathyroid hormone (1-34) as a daily subcutaneous injection].
    Sowa H, Hamaya E, Yamamoto T.
    Clin Calcium; 2011 Jan 21; 21(1):9-16. PubMed ID: 21187589
    [Abstract] [Full Text] [Related]

  • 19. Reduced risk of back pain following teriparatide treatment: a meta-analysis.
    Nevitt MC, Chen P, Dore RK, Reginster JY, Kiel DP, Zanchetta JR, Glass EV, Krege JH.
    Osteoporos Int; 2006 Feb 21; 17(2):273-80. PubMed ID: 16142502
    [Abstract] [Full Text] [Related]

  • 20. [Efficacy of teriparatide in treatment of glucocorticoid-induced osteoporosis].
    Soen S.
    Clin Calcium; 2012 Mar 21; 22(3):315-20. PubMed ID: 22370297
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.